We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.40 | -8.70% | 4.20 | 4.10 | 4.30 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 4.60 | 4.20 | 4.60 | 880,716 | 09:00:16 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.14M | -2.23M | -0.0233 | -1.80 | 4.39M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/11/2024 | 07:00 | UK RNS | Fusion Antibodies PLC Half-year Report |
| 16/10/2024 | 12:23 | UK RNS | Fusion Antibodies PLC Director/PDMR Shareholding |
| 16/10/2024 | 06:00 | UK RNS | Fusion Antibodies PLC Issue of shares to non-executive directors |
| 08/10/2024 | 12:58 | ALNC |  IN BRIEF: Fusion Antibodies expects interim revenue to double |
| 08/10/2024 | 11:32 | UK RNS | Fusion Antibodies PLC Result of AGM |
| 08/10/2024 | 06:00 | UK RNS | Fusion Antibodies PLC AGM statement and trading update |
| 02/10/2024 | 06:00 | UK RNS | Fusion Antibodies PLC Block admission six monthly return |
| 12/9/2024 | 08:54 | UK RNS | Fusion Antibodies PLC Notice of AGM |
| 09/9/2024 | 11:35 | UK RNS | Fusion Antibodies PLC Director/PDMR Shareholding |
| 09/9/2024 | 06:00 | UK RNS | Fusion Antibodies PLC Investor presentation |
1 Year Fusion Antibodies Chart |
Intraday Fusion Antibodies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
